DVB-RCS
DVB-RCS is an acronym for Digital Video Broadcasting - Return Channel via Satellite or (Return channel over system). It is a specification for an interactive on-demand multimedia satellite communication system formulated in 1999 by the DVB consortium.
Chronology
The 5th revision of the DVB-RCS standard was completed in 2008. A major update included the very first broadband mobile standardization. This extended version, formally referred to as "ETSI EN 301 790 v 1.5.1" is also known as "DVB-RCS+M". The "+M" version added several new features, such as the ability to use "DVB-S2" bursts in the uplink channel back to the satellite. It incorporated signal fade mitigation techniques and other solutions to combat short term signal loss.
In contrast to other satellite communications systems, DVB-RCS was created in an open environment where any DVB member can participate. DVB membership is open to all companies willing to subscribe. The work group called "DVB TM-RCS" is currently pursuing other technical solutions for the approved commercial system.
RCS
RCS may refer to:
Organisations
Places
Science
Technology
Computing
Other
See also
RCS-8
RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, is a synthetic cannabinoid also known as SR-18 or BTM-8 that has been found as an ingredient of "herbal" synthetic cannabis blends. It can be described as an analogue of JWH-250 with the 1-pentyl group replaced by 1-(2-cyclohexylethyl), and can be expected to be less potent than JWH-250 (cf. JWH-007 and its cyclohexylethyl analogue). Despite not having been reported in the scientific or patent literature as yet, reputed recreational use of RCS-8 in the United States has led to it being specifically listed in a proposed 2011 amendment to the Controlled Substances Act, aiming to add a number of synthetic drugs into Schedule I.
See also
References
RCS-4
RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole, is a synthetic cannabinoid drug sold under the names SR-19, BTM-4, or Eric-4 (later shortened to E-4), but originally, OBT-199.
Pharmacology
RCS-4 is a potent cannabinoid receptor agonist, with EC50 values of 146 nM for human CB1 receptors, and 46 nM for human CB2 receptors. All methoxyphenyl regiosiomers, and N-butyl homologues of RCS-4 and its regiosiomers also display potent agonist activities at CB1 and CB2 receptors.
Legality
RCS-4 was banned in Sweden on 1 October 2010 as a hazardous good harmful to health, after being identified as an ingredient in "herbal" synthetic cannabis products.
It was outlawed in Denmark on 11 March 2011.
In August 2011, New Zealand added not only RCS-4 but also its 1-butyl homologue, and the 2-methoxybenzoyl isomers of both these compounds, to a temporary class drug schedule (i.e. equivalent to Class C but reviewed after 12 months, and with personal possession and use of small amounts decriminalised), which was newly created under the Misuse of Drugs Amendment Act 2011 passed a week earlier.
DVB
DVB may refer to:
Podcasts:
